AdaptHealth (AHCO) Non-Current Deffered Revenue (2018 - 2019)
AdaptHealth (AHCO) recorded quarterly Non-Current Deffered Revenue of $7.9 million in Q3 2019, little changed quarter-over-quarter from $7.9 million in Q2 2019, and little changed on a YoY basis from $7.9 million in Q3 2018.
AdaptHealth (AHCO) Non-Current Deffered Revenue (2018 - 2019) Analysis & Trends
AdaptHealth's Non-Current Deffered Revenue history runs 2 years deep, the most recent figure standing at $7.9 million for Q3 2019.
- In Q3 2019, Non-Current Deffered Revenue changed 0.0% year-over-year to $7.9 million; the TTM figure through Sep 2019 stood at $7.9 million (changed 0.0% YoY), while the FY2018 annual figure was $7.9 million, changed N/A from the prior year.
- Non-Current Deffered Revenue was $7.9 million for Q3 2019 at AdaptHealth, roughly flat from $7.9 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $7.9 million in Q1 2018 to a low of $7.9 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | AdaptHealth | 1.30 Bn | 1.26 Bn | 111.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 7.88 Mn |
| Jun 30, 2019 | 7.88 Mn |
| Mar 31, 2019 | 7.88 Mn |
| Dec 31, 2018 | 7.88 Mn |
| Sep 30, 2018 | 7.88 Mn |
| Jun 30, 2018 | 7.88 Mn |
| Mar 31, 2018 | 7.88 Mn |